about
Transglutaminase 2 undergoes a large conformational change upon activationCeliac disease: prevalence, diagnosis, pathogenesis and treatmentIdentification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprueCeliac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantationIdentification of transglutaminase-mediated deamidation sites in a recombinant alpha-gliadin by advanced mass-spectrometric methodologiesCeliac disease: pathophysiology, clinical manifestations, and associated autoimmune conditionsEpidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformisA role for tissue transglutaminase in alpha-gliadin peptide cytotoxicityThe cross-talk between enterocytes and intraepithelial lymphocytesDietary gluten and the development of type 1 diabetesInvolvement of heat shock proteins in gluten-sensitive enteropathySupport for patients with celiac disease: A literature reviewDiagnosis of celiac disease.HLA in coeliac disease families: a novel test of risk modification by the 'other' haplotype when at least one DQA1*05-DQB1*02 haplotype is carriedGluten sensitivity in patients with primary Sjögren's syndromeCellular functions of tissue transglutaminaseNo evidence of association of the MYO9B polymorphisms with celiac disease in the Spanish populationGliadin peptides induce tissue transglutaminase activation and ER-stress through Ca2+ mobilization in Caco-2 cellsMeta and pooled analysis of European coeliac disease data.Molecular characterization of covalent complexes between tissue transglutaminase and gliadin peptides.Mass spectrometry in the characterization of cereal seed proteins.Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa.Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients.Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoireNo association between biopsy-verified celiac disease and subsequent amyotrophic lateral sclerosis--a population-based cohort study.The preferred substrates for transglutaminase 2 in a complex wheat gluten digest are Peptide fragments harboring celiac disease T-cell epitopesNovel immune response to gluten in individuals with schizophreniaIdentification of gliadin-binding peptides by phage display.Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular traffickingAn algorithm for family screening for coeliac diseaseA functional variant in the CD209 promoter is associated with DQ2-negative celiac disease in the Spanish population.Celiac disease in South-West of Iran.HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac diseaseClinical utility of celiac disease-associated HLA testingImpact of dietary gluten on regulatory T cells and Th17 cells in BALB/c mice.Nature and function of gastrointestinal antigen-presenting cells.Tissue transglutaminase treatment leads to concentration-dependent changes in dendritic cell phenotype--implications for the role of transglutaminase in coeliac disease.Celiac disease in an elite female collegiate volleyball athlete: a case reportGenetic background for immune-mediated diseases.
P2860
Q21092747-B8F454E5-D621-4D7A-A05A-49294ACF5201Q22305490-96516B90-2888-451A-B4F4-3603AC0EAAEBQ24538575-4AC11D8B-6368-4A58-9E8F-057DFF176C27Q24642835-B2E43ABC-B21B-47EB-8623-F0E62D86A7ECQ24646948-645BE14C-A8B7-4F22-A3BC-09CAA4DCB05EQ24658242-C0075644-81EC-4BC9-AC49-A10A067ECDE5Q24674416-B8C7A4AE-0879-480A-8924-9CD47BFD5B2BQ24683342-AA50C3F4-8A91-4CA1-890B-77CD5AED6C64Q26744126-2B2E0D01-E89F-445C-A5D1-ECB21798814DQ26823584-81326650-292D-4E31-8E91-4B391033B72CQ27008022-019A382E-6D9A-4111-B8AD-B49C42820FD6Q27026918-34513C79-757C-47A1-8B9F-5FF614AE06CAQ27691443-DC14EF03-74F2-47DE-BB2D-5CEF7B8DAD38Q28209245-9A791AFC-68E7-4526-8FA6-ADF6EA5716A4Q28235449-2DDF58E0-A2AF-48C7-AAFD-375BF0133EB8Q28260600-3BC2D9F2-8CF2-46CC-B1E9-64375DF4D82DQ28279518-5C617067-D9B3-4AE7-9B76-B8DD7BDBCDC3Q28484010-2C6E9F87-3060-4838-B765-C7300D20C897Q30882639-614756AA-BF8C-4F63-B0D8-2B0BB61ACB2BQ31038697-7F0C11AA-374C-429C-95C5-A8D59591A674Q31075928-0BDCD6A5-A0B1-4538-8A04-E210E3DC9A8DQ31091532-3F0EA4F9-8364-4BB9-B0D0-84A26287A058Q33195266-FFD7BFB8-D892-4501-AAE7-00E690D5AB50Q33261291-83ED5210-B950-453B-86D5-11CCC34F3FF2Q33582318-0D30601C-2955-43B4-B07A-772A7DD05393Q33754218-7566FF8E-FBEE-4A02-BA25-6A81DE704B8FQ33761129-C54AF1BD-FE29-40A7-9FA8-9872FD8F67D5Q33798660-4F2EE717-3C9F-48B7-909A-AB54A1137700Q33823074-3080467A-62B7-426B-B4C3-291B70138406Q33833760-EA28A906-C83D-465C-B334-E67D39F0A748Q33866706-6075A4F7-E223-4E31-9E3C-4D4BD5A0AD22Q33867573-0F47306F-837A-4D29-BE0E-E329BAB2A069Q33867593-C862C502-5836-427C-A945-68D46255AC65Q33998193-64A52A51-E48A-473F-B60A-6892D43F95E1Q34110718-7741D6E8-F71E-4604-A629-4591C8DC5107Q34200740-EE936EC8-44E2-4A97-9D10-2E631332AA2EQ34215953-119D26EA-FC3E-424D-891E-D56506F7AE3AQ34234477-DEB175B3-A318-402D-A9FC-9F7CCC3FE16FQ34245497-7E8E31EC-C459-4C61-929F-7F4B34CBDCEFQ34380109-6C6E388D-B08A-4211-8DE2-24833BA006CD
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular basis of celiac disease.
@ast
Molecular basis of celiac disease.
@en
type
label
Molecular basis of celiac disease.
@ast
Molecular basis of celiac disease.
@en
prefLabel
Molecular basis of celiac disease.
@ast
Molecular basis of celiac disease.
@en
P1476
Molecular basis of celiac disease.
@en
P2093
P356
10.1146/ANNUREV.IMMUNOL.18.1.53
P577
2000-01-01T00:00:00Z